Related Experiment Video
Updated: Jun 11, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Follicular Skin Disorders, Inflammatory Bowel Disease, and the Microbiome: A Systematic Review
Lauren Fleshner1, Katie Roster2, Banu Farabi1,3
1School of Medicine, New York Medical College, Valhalla, NY 10595, USA.
This review links gut microbiome changes to hidradenitis suppurativa (HS) and inflammatory bowel disease (IBD). Dietary changes may help manage these conditions by impacting the microbiome.
Area of Science:
- Dermatology and Gastroenterology
- Microbiome Research
Background:
- Follicular skin disorders like hidradenitis suppurativa (HS) often co-occur with systemic autoinflammatory diseases, notably inflammatory bowel disease (IBD).
- Gut microbiome dysbiosis is a suspected pathogenic link between HS and IBD, but its comprehensive role across gut, skin, and blood remains unclear.
Purpose of the Study:
- To systematically review the relationship between follicular skin disorders, IBD, and the human microbiome.
- To explore potential therapeutic interventions targeting the microbiome.
Main Methods:
- Systematic literature review of sixteen studies.
- Analysis of studies investigating diet, bacterial colonization, serological biomarkers, and concurrent HS and IBD patient data.
Main Results:
- Dietary modifications, particularly yeast-exclusion diets, may influence the microbiome in HS patients.
- Specific gut and skin bacteria (e.g., Enterococcus, Veillonella) are associated with HS severity.
- Common immunological markers, including elevated cytokines and T-lymphocytes, are found in HS patients with autoinflammatory diseases like IBD.
Conclusions:
- A complex interplay exists between the microbiome, IBD, and follicular disorders, especially HS.
- Dietary interventions show promise for managing HS and IBD.
- Further research on microbiota analysis and serological biomarkers is essential to understand dysbiosis's role.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

